Found: 9
Select item for more details and to access through your institution.
Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 13, doi. 10.3390/pharmaceutics15010013
- By:
- Publication type:
- Article
Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 11, p. 2348, doi. 10.3390/pharmaceutics14112348
- By:
- Publication type:
- Article
Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071392
- By:
- Publication type:
- Article
Micro- and Nano-Systems Developed for Tolcapone in Parkinson's Disease.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 1080, doi. 10.3390/pharmaceutics14051080
- By:
- Publication type:
- Article
Sulfasalazine Microparticles Targeting Macrophages for the Treatment of Inflammatory Diseases Affecting the Synovial Cavity.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 7, p. 951, doi. 10.3390/pharmaceutics13070951
- By:
- Publication type:
- Article
Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 1959, doi. 10.2147/IJN.S130908
- By:
- Publication type:
- Article
Compatibility and Stability of Ternary Admixtures of Tramadol, Haloperidol, and Hyoscine N-Butyl Bromide: Retrospective Clinical Evaluation.
- Published in:
- Journal of Palliative Medicine, 2010, v. 13, n. 3, p. 273, doi. 10.1089/jpm.2009.0187
- By:
- Publication type:
- Article
Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.
- Published in:
- Supportive Care in Cancer, 2007, v. 15, n. 1, p. 57, doi. 10.1007/s00520-006-0101-2
- By:
- Publication type:
- Article
Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis.
- Published in:
- AAPS PharmSciTech, 2020, v. 21, n. 1, p. 1, doi. 10.1208/s12249-019-1552-3
- By:
- Publication type:
- Article